Predict your next investment

Other

See what CB Insights has to offer

Investments

5

About Xiangrong Investment

Xiangrong Investment is based in China.

Xiangrong Investment Headquarter Location

Shanghai, Shanghai,

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Xiangrong Investment Investments

5 Investments

Xiangrong Investment has made 5 investments. Their latest investment was in Shineyo Medical as part of their Seed VC on September 9, 2021.

CBI Logo

Xiangrong Investment Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/9/2021

Seed VC

Shineyo Medical

Yes

1

3/26/2019

Unattributed

Subscribe to see more

Subscribe to see more

10

12/12/2018

Seed VC

Subscribe to see more

Subscribe to see more

10

1/17/2018

Seed VC

Subscribe to see more

Subscribe to see more

10

9/5/2017

Series B

Subscribe to see more

Subscribe to see more

10

Date

9/9/2021

3/26/2019

12/12/2018

1/17/2018

9/5/2017

Round

Seed VC

Unattributed

Seed VC

Seed VC

Series B

Company

Shineyo Medical

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

10

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.